Article
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
8 Sept 2021
Abstract excerpt
BACKGROUND: Despite the emergence of diagnostic and clinical utility evidence in nephrology, publicly funded access to genomic testing is restricted in most health care systems. To establish genomic sequencing as a clinical test, an evaluation of cost-effectiveness is urgently required. METHODS: An economic evaluation, informed by a primary clinical study and available clinical evidence and guidelines in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
